| Annual Financials | 2020 | 2021 | TTM |
Revenue  | 544 | 508 | 0 |
| Expenses | 325 | 293 | 0 |
| EBITDA | 220 | 215 | 0 |
| Operating Profit % | 40 % | 41 % | 0 % |
| Depreciation | 18 | 20 | 0 |
| Interest | 7 | 5 | 0 |
| Profit Before Tax | 194 | 185 | 0 |
| Tax | 49 | 49 | 0 |
| Net Profit | 145 | 136 | 0 |
| EPS in ₹ | 1,462.60 | 1,396.27 | 0.00 |
Blue Jet Healthcare
Blue Jet Healthcare
598.15
+36.50
(6.50%)
Q1 Quarterly Results are out. Check out the updated financials2 days ago
View
Key Fundamentals
Market Cap
9,742.70 Cr
EPS
1,396.27
PE Ratio
29.52
Dividend Yield
0.20 %
Industry
Healthcare 52 Week High
1,027.80
52 Week Low
492.00
PB Ratio
8.28
Debt to Equity
0.24
Sector
Pharmaceuticals Analyst Rating and Forecast
- By Refinitiv from6 analysts
Actual
Company News
View All News
Blue Jet Healthcare Declines to Provide Specific Financial Guidance2 days ago
Blue Jet Healthcare management stated they do not provide specific financial guidance or predictions. During analyst interactions, the company emphasized having good visibility into future demand but prefers to avoid making specific forecasts. Management directed analysts to examine historical trends and aggregated numbers instead of seeking specific performance predictions.
BlueJet Healthcare Reports Mixed Q2FY26 Results with 53% Revenue Decline but Strong Half-Year Growth
3 days ago
3 days agoBlueJet Healthcare reported revenue from operations of Rs. 1,655 mn in Q2FY26, down 53% from Q1FY26's Rs. 3,548 mn. EBITDA stood at Rs. 549 mn with 33% margin, while PAT was Rs. 521 mn with 32% margin. The revenue decline was attributed to lower sales in pharmaceutical intermediates segment due to channel inventory de-stocking. However, half-year results showed strong performance with H1FY26 revenue at Rs. 5,202 mn, up 40% year-on-year from Rs. 3,712 mn in H1FY25. EBITDA increased 55% to Rs. 1,759 mn and PAT grew 49% to Rs. 1,433 mn. The company launched a new iodinated contrast media intermediate and reported robust growth in MRI segment contrast media. Cash and treasury investments increased to Rs. 3,413 mn as of September 30, 2025. The company acquired 102 acres of land near Vizag for Rs. 42 crores and incurred capex investment of over Rs. 82 crores during April-September 2025.
Blue Jet Healthcare reported Q2 revenue of 1.66 billion rupees, down from 2.1 billion rupees in the same period last year. Net profit decreased to 521 million rupees from 584 million rupees year-over-year. EBITDA fell to 550 million rupees compared to 694 million rupees in the previous year, while EBITDA margin remained relatively stable at 33.21% versus 33.33% year-over-year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,691.40 | #1 4,04,503.90 | 38.74 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 55.98 | |
6,656.50 | 1,82,735.30 | 71.11 | 9,712.00 | 18.67 | 2,191 | 35.10 | 58.39 | |
1,505.70 | 1,21,284.30 | 22.36 | 28,409.50 | 7.12 | 5,291 | 3.71 | 40.84 | |
3,580.00 | 1,21,163.50 | 60.51 | 11,539.40 | 6.99 | 1,911 | 30.46 | 50.54 | |
1,205.40 | 1,00,587.70 | #1 17.53 | 33,741.20 | 16.73 | 5,725 | -0.38 | 37.06 | |
2,261.80 | 95,310.10 | 52.66 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 25.15 | |
944.10 | 94,998.60 | 18.88 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.87 | |
1,971.80 | 89,318.30 | 20.71 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 53.33 | |
5,668.50 | 67,476.50 | 29.08 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.91 | |
1,123.80 | 66,246.20 | 19.24 | 32,345.60 | 9.43 | 3,484 | 3.81 | 53.78 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-6.62 %
Net Income Growth
-6.34 %
Cash Flow Change
5.34 %
ROE
-44.11 %
ROCE
-38.82 %
EBITDA Margin (Avg.)
4.85 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 |
| Total Assets | 375 | 536 |
| Fixed Assets | 107 | 139 |
| Current Assets | 249 | 390 |
| Capital Work in Progress | 2 | 3 |
| Investments | 34 | 37 |
| Other Assets | 233 | 358 |
| Total Liabilities | 375 | 536 |
| Current Liabilities | 133 | 163 |
| Non Current Liabilities | 39 | 33 |
| Total Equity | 203 | 340 |
| Reserve & Surplus | 182 | 320 |
| Share Capital | 1 | 10 |
Cash Flow
| Cash Flow | 2020 | 2021 |
| Net Cash Flow | 5 | 51 |
| Investing Activities | -45 | -51 |
| Operating Activities | 123 | 129 |
| Financing Activities | -73 | -28 |
Share Holding
| % Holding | Sept 2022 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 100.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 79.81 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 2.01 % | 2.02 % | 2.18 % | 1.10 % | 2.29 % | 1.97 % | 1.82 % |
| DIIs | 0.00 % | 3.32 % | 2.81 % | 3.03 % | 2.14 % | 1.74 % | 2.02 % | 1.33 % | 0.94 % | 3.63 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 6.97 % | 4.73 % | 5.36 % | 5.79 % | 5.90 % | 6.30 % | 7.28 % | 8.03 % | 9.78 % |
| Others | 0.00 % | 3.71 % | 6.46 % | 3.60 % | 4.04 % | 4.17 % | 4.57 % | 3.10 % | 3.05 % | 4.95 % |
| No of Share Holders | 7 | 2,03,777 | 55,589 | 48,625 | 42,882 | 41,933 | 43,003 | 54,581 | 70,772 | 80,117 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.2 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.2 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 Sept 2024 |  Dividend | ₹ 1.00 /share | 17 Sept 2024 | 375.60 | 526.85 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 517.20 | 537.80 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 473.65 | 480.30 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 581.00 | 572.95 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 723.30 | 769.30 |
| 22 Jul 2025 | Quarterly Result Announcement | NA | 22 Jul 2025 | 955.20 | 1,006.80 |
| 19 Sept 2025 | Dividend | ₹ 1.20 /share | 19 Sept 2025 | 769.30 | 683.55 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 770.70 | 664.85 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 638.55 | 674.75 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation3 days ago
3 days agoUnaudited Financial Result For The Quarter And Half Year Ended September 30 20253 days ago
3 days agoBoard Meeting Outcome for Unaudited Standalone Financial Result For The Quarter And Half Year Ended Sep 20253 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoBoard Meeting Intimation for Approval Of The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 Along With Limited Review Report As Received From The Statutory Auditor Of The Company9 days ago
9 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Sep 26, 2025Receipt Of Excellent Energy Efficient Unit At 26Th National Award For Excellence In Energy Management 2025 By The Blue Jet Healthcare LimitedSep 19, 2025
Sep 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Sep 18, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 15, 2025
Sep 15, 2025Announcement Under Regulation 30 (LODR)-Offer For SaleSep 12, 2025
Sep 12, 2025Updates on Notice of Offer for Sale of Shares by PromoterSep 10, 2025
Sep 10, 2025Notice of Offer for Sale of Shares by Promoterse & Floor PriceSep 09, 2025
Sep 09, 2025Notice of Offer for Sale of Shares by Promoter & Floor PriceSep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 02, 2025
Sep 02, 2025Notice Of The 57Th Annual General Meeting Of Blue Jet Healthcare LimitedSep 02, 2025
Sep 02, 2025Reg. 34 (1) Annual Report.Sep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Appointment Of Secretarial AuditorAug 22, 2025
Aug 22, 2025Corporate Action - Fixed Record Date For Dividend As September 19 2025Aug 22, 2025
Aug 22, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 22, 2025
Aug 22, 2025Board Meeting Outcome for Board Meeting OutcomeAug 22, 2025
Aug 22, 2025Announcement Under Regulation 30 - Acquisition Of Land And Investment ApprovalJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 22, 2025
Jul 22, 2025Unaudited Financial Result For June 30 2025Jul 22, 2025
Jul 22, 2025Board Meeting Outcome for Unaudited Standalone Financial Results Along With LRR For Quarter Ended June 30 2025Jul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2025
Jul 16, 2025Board Meeting Intimation for Unaudited Financial Result Along With LRR For The Quarter Ended June 30 2025Jul 15, 2025
Jul 15, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 11, 2025
Jul 11, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 16, 2025
Jun 16, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 16, 2025
Jun 16, 2025Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 29, 2025
May 29, 2025Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015May 22, 2025
May 22, 2025Disclosure under Regulation 30A of LODRMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
May 16, 2025Notice Of Postal BallotMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2025
May 14, 2025Mutual Fund Holdings
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 
PGIM India Flexi Cap Fund Direct-Growth 
JM Flexicap Fund Direct Plan-Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Groww Nifty Smallcap 250 Index Fund Direct - Growth 
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth 
Kotak Nifty Smallcap 250 Index Fund Direct-Growth 
Axis Nifty 500 Index Fund Direct-Growth 
Motilal Oswal Quant Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 39.26
ATR(14)
Volatile 29.57
STOCH(9,6)
Neutral 37.70
STOCH RSI(14)
Oversold 13.92
MACD(12,26)
Bearish -5.08
ADX(14)
Weak Trend 20.15
UO(9)
Bearish 38.84
ROC(12)
Downtrend And Accelerating -9.53
WillR(14)
Neutral -62.40
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
